Craig C. Hopkinson, EVP R&D, Chief Medical Officer at Alkermes plc. (ALKS), sold 201,836 shares at $32.05 ($6.5M) on 2025-01-30, disclosed to the SEC on 2025-01-31.
Scheduled sale ($6.5M) by EVP R&D, Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.05 | 100,918 | $3.2M | 50.0% |
| 2 | $32.05 | 100,918 | $3.2M | 50.0% |
| Total | $32.05 avg | 201,836 | $6.5M | 100% |
| Filing → |
| ALKS | SELL | 2026-07-01 | $464K | — | Filing → |
| ALKS | SELL | 2026-06-01 | $375K | — | Filing → |
| ALKS | SELL | 2026-05-01 | $301K | — | Filing → |